Phreesia Set to Release Earnings After Market Close Tomorrow

NEW YORK, NY — Healthcare technology company Phreesia is set to report its quarterly earnings results tomorrow after market hours. Investors are eager to learn how the company performed in the first quarter of 2026.

Last quarter, Phreesia exceeded analysts’ revenue expectations by 0.7%, reporting revenues of $109.7 million, up 15.4% year on year. The results marked a strong performance, with the company also beating earnings per share (EPS) estimates and providing full-year EBITDA guidance above analysts’ forecasts.

During the last quarter, Phreesia added 104 customers, bringing its total to 4,341. For the current quarter, analysts estimate a revenue growth of 13.8% year on year to $115.2 million, a slowdown compared to the 20.7% growth seen in the same quarter last year. Adjusted earnings are projected at $0.16 per share.

Over the past month, analysts have reaffirmed their estimates, suggesting confidence in the company’s performance as it approaches earnings day. Phreesia has consistently outperformed Wall Street’s expectations, having beaten revenue estimates on average by 1.2% over the past two years.

Looking at competitors in the healthcare technology segment, some have already released their Q1 results, providing context for Phreesia’s performance. Premier reported a revenue decrease of 8.9% year on year but still beat forecasts by 7.4%, and Privia Health saw an increase of 15.6%, surpassing estimates by 6.5%. Following their earnings, Premier’s stock rose by 12.4%, while Privia Health’s shares increased by 7.2%.

The healthcare technology sector has seen steady trading habits, with average share prices down 1.3% over the past month. Phreesia’s stock price remained unchanged during this period, and analysts have set an average price target of $31.77, compared to the current share price of $24.40.

As excitement builds ahead of the earnings report, investors will be keen to see if Phreesia’s performance aligns with the positive trends noted among its competitors.